US Stock MarketDetailed Quotes

Taysha Gene Therapies (TSHA)

Watchlist
  • 6.300
  • -0.370-5.55%
Close May 14 16:00 ET
  • 6.260
  • -0.040-0.63%
Pre 05:41 ET
1.81BMarket Cap-16.58P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taysha Gene Therapies (TSHA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-85.64%-40.88M
-14.61%-93.09M
-45.96%-26.72M
-11.80%-24.17M
6.15%-20.18M
-11.22%-22.02M
-11.24%-81.23M
-13.59%-18.31M
-20.42%-21.62M
-14.58%-21.5M
Net income from continuing operations
-96.99%-42.41M
-22.06%-109M
-48.26%-27.85M
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
Operating gains losses
----
7,593.75%1.2M
986.75%736K
489.33%292K
240.00%273K
-130.27%-102K
-100.04%-16K
99.87%-83K
---75K
---195K
Depreciation and amortization
4.24%295K
-8.03%1.15M
-1.64%299K
-2.72%286K
-13.98%277K
-12.92%283K
-9.19%1.25M
-16.94%304K
-11.18%294K
-6.12%322K
Other non cash items
-41.69%344K
311.24%5.63M
1,113.09%3.64M
-51.13%673K
197.17%734K
461.90%590K
-86.48%1.37M
-113.92%-359K
-55.09%1.38M
-93.92%247K
Change In working capital
-2.15%-4.65M
56.92%-5.37M
-171.90%-7.07M
168.53%4.03M
151.99%2.23M
-1,628.86%-4.56M
30.79%-12.47M
46.35%-2.6M
20.20%-5.88M
-437.94%-4.28M
-Change in prepaid assets
24.52%-794K
-937.68%-1.73M
-360.68%-2.14M
231.04%971K
-41.36%482K
-51.80%-1.05M
-96.56%207K
-59.11%819K
-121.18%-741K
-9.57%822K
-Change in payables and accrued expense
-221.13%-3.86M
241.35%6.14M
139.20%548K
191.26%3.06M
193.44%3.73M
-127.31%-1.2M
49.36%-4.34M
56.94%-1.4M
45.25%-3.35M
-678.55%-3.99M
-Change in other working capital
----
-17.28%-9.77M
-171.27%-5.49M
--0
-78.60%-1.99M
32.51%-2.3M
46.07%-8.33M
43.90%-2.02M
62.33%-1.79M
53.57%-1.11M
Cash from discontinued investing activities
Operating cash flow
-85.64%-40.88M
-14.61%-93.09M
-45.96%-26.72M
-11.80%-24.17M
6.15%-20.18M
-11.22%-22.02M
-11.24%-81.23M
-13.59%-18.31M
-20.42%-21.62M
-14.58%-21.5M
Investing cash flow
Cash flow from continuing investing activities
-715.09%-3.02M
-66.39%-604K
-2,000.00%-247K
-37.14%-48K
130.85%62K
-165.00%-371K
95.06%-363K
230.00%13K
99.00%-35K
-518.75%-201K
Net PPE purchase and sale
93.65%-24K
-97.33%-738K
-12,600.00%-250K
-208.57%-108K
99.00%-2K
-170.00%-378K
90.33%-374K
111.76%2K
---35K
-518.75%-201K
Net intangibles purchase and sale
---3M
----
----
----
----
--0
--0
--0
----
----
Net other investing changes
----
1,118.18%134K
--3K
--60K
--64K
--7K
-35.29%11K
----
----
----
Cash from discontinued investing activities
Investing cash flow
-715.09%-3.02M
-66.39%-604K
-2,000.00%-247K
-37.14%-48K
130.85%62K
-165.00%-371K
95.06%-363K
230.00%13K
99.00%-35K
-518.75%-201K
Financing cash flow
Cash flow from continuing financing activities
1,467.31%711K
258.08%274.59M
13,981.23%49.56M
33.39%8.8M
206.93%216.29M
-136.36%-52K
-43.78%76.68M
91.60%-357K
-95.31%6.6M
18,591.78%70.47M
Net issuance payments of debt
----
--9.24M
--0
----
----
----
--0
--0
----
----
Net common stock issuance
----
244.24%264.31M
13,597.22%48.59M
-106.82%-454K
----
----
-45.46%76.78M
14.89%-360K
-95.27%6.66M
----
Proceeds from stock option exercised by employees
822.67%692K
1,449.44%1.38M
2,657.50%1.02M
172.82%281K
--0
188.46%75K
30.88%89K
---40K
472.22%103K
--0
Net other financing activities
114.96%19K
-82.16%-337K
-232.56%-57K
-62.28%-271K
1,007.69%118K
-164.58%-127K
81.77%-185K
111.47%43K
-72.16%-167K
89.43%-13K
Cash from discontinued financing activities
Financing cash flow
1,467.31%711K
258.08%274.59M
13,981.23%49.56M
33.39%8.8M
206.93%216.29M
-136.36%-52K
-43.78%76.68M
91.60%-357K
-95.31%6.6M
18,591.78%70.47M
Net cash flow
Beginning cash position
127.72%322.53M
-3.35%141.64M
87.13%299.94M
79.85%315.36M
-5.84%119.19M
-3.35%141.64M
61.89%146.54M
-3.97%160.29M
267.44%175.34M
91.61%126.58M
Current changes in cash
-92.45%-43.19M
3,788.72%180.9M
221.10%22.59M
-2.40%-15.42M
302.29%196.17M
-12.44%-22.44M
-108.75%-4.9M
8.46%-18.65M
-112.63%-15.06M
365.85%48.76M
End cash Position
134.36%279.34M
127.72%322.53M
127.72%322.53M
87.13%299.94M
79.85%315.36M
-5.84%119.19M
-3.35%141.64M
-3.35%141.64M
-3.97%160.29M
267.44%175.34M
Free cash flow
-96.01%-43.9M
-14.99%-93.83M
-47.34%-26.97M
-12.12%-24.27M
7.01%-20.18M
-12.34%-22.4M
-1.51%-81.6M
-13.46%-18.31M
-0.94%-21.65M
-15.95%-21.71M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -85.64%-40.88M-14.61%-93.09M-45.96%-26.72M-11.80%-24.17M6.15%-20.18M-11.22%-22.02M-11.24%-81.23M-13.59%-18.31M-20.42%-21.62M-14.58%-21.5M
Net income from continuing operations -96.99%-42.41M-22.06%-109M-48.26%-27.85M-28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M
Operating gains losses ----7,593.75%1.2M986.75%736K489.33%292K240.00%273K-130.27%-102K-100.04%-16K99.87%-83K---75K---195K
Depreciation and amortization 4.24%295K-8.03%1.15M-1.64%299K-2.72%286K-13.98%277K-12.92%283K-9.19%1.25M-16.94%304K-11.18%294K-6.12%322K
Other non cash items -41.69%344K311.24%5.63M1,113.09%3.64M-51.13%673K197.17%734K461.90%590K-86.48%1.37M-113.92%-359K-55.09%1.38M-93.92%247K
Change In working capital -2.15%-4.65M56.92%-5.37M-171.90%-7.07M168.53%4.03M151.99%2.23M-1,628.86%-4.56M30.79%-12.47M46.35%-2.6M20.20%-5.88M-437.94%-4.28M
-Change in prepaid assets 24.52%-794K-937.68%-1.73M-360.68%-2.14M231.04%971K-41.36%482K-51.80%-1.05M-96.56%207K-59.11%819K-121.18%-741K-9.57%822K
-Change in payables and accrued expense -221.13%-3.86M241.35%6.14M139.20%548K191.26%3.06M193.44%3.73M-127.31%-1.2M49.36%-4.34M56.94%-1.4M45.25%-3.35M-678.55%-3.99M
-Change in other working capital -----17.28%-9.77M-171.27%-5.49M--0-78.60%-1.99M32.51%-2.3M46.07%-8.33M43.90%-2.02M62.33%-1.79M53.57%-1.11M
Cash from discontinued investing activities
Operating cash flow -85.64%-40.88M-14.61%-93.09M-45.96%-26.72M-11.80%-24.17M6.15%-20.18M-11.22%-22.02M-11.24%-81.23M-13.59%-18.31M-20.42%-21.62M-14.58%-21.5M
Investing cash flow
Cash flow from continuing investing activities -715.09%-3.02M-66.39%-604K-2,000.00%-247K-37.14%-48K130.85%62K-165.00%-371K95.06%-363K230.00%13K99.00%-35K-518.75%-201K
Net PPE purchase and sale 93.65%-24K-97.33%-738K-12,600.00%-250K-208.57%-108K99.00%-2K-170.00%-378K90.33%-374K111.76%2K---35K-518.75%-201K
Net intangibles purchase and sale ---3M------------------0--0--0--------
Net other investing changes ----1,118.18%134K--3K--60K--64K--7K-35.29%11K------------
Cash from discontinued investing activities
Investing cash flow -715.09%-3.02M-66.39%-604K-2,000.00%-247K-37.14%-48K130.85%62K-165.00%-371K95.06%-363K230.00%13K99.00%-35K-518.75%-201K
Financing cash flow
Cash flow from continuing financing activities 1,467.31%711K258.08%274.59M13,981.23%49.56M33.39%8.8M206.93%216.29M-136.36%-52K-43.78%76.68M91.60%-357K-95.31%6.6M18,591.78%70.47M
Net issuance payments of debt ------9.24M--0--------------0--0--------
Net common stock issuance ----244.24%264.31M13,597.22%48.59M-106.82%-454K---------45.46%76.78M14.89%-360K-95.27%6.66M----
Proceeds from stock option exercised by employees 822.67%692K1,449.44%1.38M2,657.50%1.02M172.82%281K--0188.46%75K30.88%89K---40K472.22%103K--0
Net other financing activities 114.96%19K-82.16%-337K-232.56%-57K-62.28%-271K1,007.69%118K-164.58%-127K81.77%-185K111.47%43K-72.16%-167K89.43%-13K
Cash from discontinued financing activities
Financing cash flow 1,467.31%711K258.08%274.59M13,981.23%49.56M33.39%8.8M206.93%216.29M-136.36%-52K-43.78%76.68M91.60%-357K-95.31%6.6M18,591.78%70.47M
Net cash flow
Beginning cash position 127.72%322.53M-3.35%141.64M87.13%299.94M79.85%315.36M-5.84%119.19M-3.35%141.64M61.89%146.54M-3.97%160.29M267.44%175.34M91.61%126.58M
Current changes in cash -92.45%-43.19M3,788.72%180.9M221.10%22.59M-2.40%-15.42M302.29%196.17M-12.44%-22.44M-108.75%-4.9M8.46%-18.65M-112.63%-15.06M365.85%48.76M
End cash Position 134.36%279.34M127.72%322.53M127.72%322.53M87.13%299.94M79.85%315.36M-5.84%119.19M-3.35%141.64M-3.35%141.64M-3.97%160.29M267.44%175.34M
Free cash flow -96.01%-43.9M-14.99%-93.83M-47.34%-26.97M-12.12%-24.27M7.01%-20.18M-12.34%-22.4M-1.51%-81.6M-13.46%-18.31M-0.94%-21.65M-15.95%-21.71M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.75%
Sample Name
Sample Code
 +15.52%
Sample Name
Sample Code
 +14.53%
4
United States Oil Fund LP
USO
+13.64%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.14%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +9.49%
Sample Name
Sample Code
 +8.77%
4
Hesai
HSAI
+8.01%
5
NIO Inc
NIO
+6.47%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -